Yet another perfect illustration why it'd be so potentially devastating to sever links between U.S. and Chinese science, as the Trump administration is trying to do.
A Chinese biotech company found what Dr Norman Sharpless, former director of the National Cancer Institute, says is the first "potential cure" he's seen in his 30 years in oncology for myeloma, a common and extremely painful blood cancer that doctors thought incurable.
A group of 97 patients who had longstanding multiple myeloma, underwent a clinical trial funded by Johnson & Johnson, which has an exclusive licensing agreement with Legend Biotech, the Chinese biotech firm that found the potential cure. A third of the patients responded so well to the treatment that they have no detectable trace of the cancer anymore, even though they used to face certain death within months.